Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility
Author(s) -
Samira Moradi,
Ali JahanianNajafabadi,
Mehryar Habibi Roudkenar
Publication year - 2016
Publication title -
clinical medicine insights blood disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 10
ISSN - 1179-545X
DOI - 10.4137/cmbd.s38461
Subject(s) - population , medicine , human blood , intensive care medicine , risk analysis (engineering) , physiology , environmental health
The 21st century is challenging for human beings. Increased population growth, population aging, generation of new infectious agents, and natural disasters are some threatening factors for the current state of blood transfusion. However, it seems that science and technology not only could overcome these challenges but also would turn many human dreams to reality in this regard. Scientists believe that one of the future evolutionary innovations could be artificial blood substitutes that might pave the way to a new era in transfusion medicine. In this review, recent status and progresses in artificial blood substitutes, focusing on red blood cells substitutes, are summarized. In addition, steps taken toward the development of artificial blood technology and some of their promises and hurdles will be highlighted. However, it must be noted that artificial blood is still at the preliminary stages of development, and to fulfill this dream, ie, to routinely transfuse artificial blood into human vessels, we still have to strengthen our knowledge and be patient.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom